ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1024

$720K Total Retail Price of All Prescriptions

Rank: 116 out of 1024

487 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 496 471 100 1 2
FUROSEMIDE 369 364* 70 2 6
SIMVASTATIN 365 350 84 3 5
AMLODIPINE BESYLATE 352 347* 67 4 3
ATORVASTATIN CALCIUM 330 315 73 5 1
OMEPRAZOLE 283 278* 57 6 9
LISINOPRIL 269 264* 60 7 4
METFORMIN HCL 237 232* 49 8 10
WARFARIN SODIUM 224 224 33 9 8
ZOLPIDEM TARTRATE 220 208 46 10 19
LOSARTAN POTASSIUM 189 189 38 11 16
METOPROLOL SUCCINATE 165 160* 33 12 12
HYDROCHLOROTHIAZIDE 163 158* 37 13 11
BYSTOLIC 143 138* 26 14 74
CRESTOR 132 132 25 15 20
GABAPENTIN 129 124* 21 16 18
METOPROLOL TARTRATE 128 123* 30 17 7
LORAZEPAM 128 128 36 B 17 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 126 29 19 42
SPIRIVA 124 124 18 20 47
OXYCODONE-ACETAMINOPHEN 120 106 44 S2 21 61
ATENOLOL 115 110* 28 22 13
CYMBALTA 106 106 16 23 35
MELOXICAM 106 106 23 23 62
TAMSULOSIN HCL 104 99* 20 25 24
CITALOPRAM HBR 102 102 18 26 37
DONEPEZIL HCL 97 97 17 27 25
ALPRAZOLAM 94 80 26 B 28 17
CLONAZEPAM 89 89 20 B 29 57
DIOVAN 89 89 11 29 21
ADVAIR DISKUS 88 88 21 31 41
MONTELUKAST SODIUM 83 78* 16 32 46
SPIRONOLACTONE 82 82 15 33 71
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 20 34 65
ESCITALOPRAM OXALATE 77 77 20 35 14
FLUTICASONE PROPIONATE 75 70* 35 36 51
NAMENDA 75 75 11 36 27
ALENDRONATE SODIUM 74 74 22 38 39
FENTANYL 74 <11 <11 S2 38 99
CELEBREX 72 72 14 40 87
PAROXETINE HCL 71 66* 14 41 72
PREDNISONE 68 68 36 42 38
SERTRALINE HCL 67 67 14 43 23
TRIAMCINOLONE ACETONIDE 66 61* 34 44 145
VENLAFAXINE HCL 63 <11 <11 45 255
OXYBUTYNIN CHLORIDE ER 62 <11 <11 46 93
NEXIUM 61 61 11 47 33
ALLOPURINOL 60 60 12 48 34
CLOPIDOGREL 60 60 13 48 28
EXELON 58 58 12 50 96
PREMARIN 57 <11 <11 R 51 271
LIDODERM 52 47* 15 52 69
OXYCONTIN 51 37 11 S2 53 102
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.